Sanofi India Limited (SANOFI.NS) Financials
SANOFI.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2024 | 16.1 billion | 7.5 billion |
| Sept. 30, 2024 | ? | ? |
| June 30, 2024 | 13.6 billion | 6.8 billion |
| March 31, 2024 | ? | ? |
SANOFI.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2024 | ? | ? |
| Sept. 30, 2024 | ? | ? |
| June 30, 2024 | ? | ? |
| March 31, 2024 | ? | ? |
SANOFI.NS Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2024 | 913.0 million |
| Sept. 30, 2024 | 822.0 million |
| June 30, 2024 | 1.0 billion |
| March 31, 2024 | 1.4 billion |
SANOFI.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2024 | 3.4 billion | 140.0 million | 193.0 million |
| Sept. 30, 2024 | - | - | - |
| June 30, 2024 | 2.6 billion | 164.0 million | 221.0 million |
| March 31, 2024 | 3.9 billion | - | - |
SANOFI.NS Shares Outstanding
SANOFI.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2024 | - | - | - | - |
| Sept. 30, 2024 | - | - | - | - |
| June 30, 2024 | - | - | 665.0 million | - |
| March 31, 2024 | - | - | 1.1 billion | - |
SANOFI.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2024 | 5.1 billion | 2.5 billion |
| Sept. 30, 2024 | 5.2 billion | 2.6 billion |
| June 30, 2024 | 4.6 billion | 2.9 billion |
| March 31, 2024 | 7.3 billion | 4.1 billion |
SANOFI.NS
Price: ₹5,855
Dividend Yield: 2.01%
Forward Dividend Yield: 2.02%
Payout Ratio: 50.99%
Dividend Per Share: 117.00 INR
Earnings Per Share: 136.32 INR
P/E Ratio: 42.73
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 134.2 billion
Average Dividend Frequency: 2
Years Paying Dividends: 23
DGR3: -7.60%
DGR5: 30.00%
DGR10: 30.00%
DGR20: 30.00%